Pages that link to "Item:Q3136503"
Jump to navigation
Jump to search
The following pages link to (Q3136503):
Displayed 50 items.
- Pre-clinical study to evaluate hybrid modulating drugs of sirtuin-1 and VEGF as a therapeutic for age-associated macular degeneration and diabetic retinopathy (Sirt-in-Eyes). (Q3136504) (← links)
- Optimisation of tissue samples for the development and validation of disease biomarkers: OPTIMARK project (Q3136976) (← links)
- Study of pediatric acute myeloid leukemia and development of disease models. (Q3139994) (← links)
- NATIONAL BIOBANK NETWORK (Q3141124) (← links)
- CHARACTERISATION OF ACTIVE HUMAN RETRONSPOSON REGULOMA (Q3143165) (← links)
- Acquisition of new analytical cytometry equipment for the CABIMER Citometry Unit. (Q3146386) (← links)
- Evaluation of cytosolic reduction of Acetyl coenzyme A as a geroprotective therapy to promote healthy aging (Q3147590) (← links)
- Standardised platelet lysate as a technological base for new lines of research and care opportunities (Q3149358) (← links)
- PRB3 BIOMOLECULAR RESOURCES PLATFORM (Q3151530) (← links)
- Gene editing as an alternative to retroviral vectors for gene therapy of Wiskott-Aldrich syndrome (Q3155014) (← links)
- Modernisation of the unit of Scientific-Technical Service of Cytogenetics and Molecular Biology of the Biobank of the Public Health System of Andalusia. (Q3155720) (← links)
- THE ROLE OF BANK1 IN TLR B CELL MARKING AND AUTOIMMUNITY (Q3155799) (← links)
- Cell Therapy Network (Tercel) (Q3157045) (← links)
- Construction and development of a multimodal diagnostic nanosystem, gallium chelating and selectively vehicularly to target cells in vivo (Q3157074) (← links)
- A MEDICAL APPROACH OF SYSTEMS BASED ON CELL PROCESS MODELS TO UNRAVEL MECHANISMS OF COMPLEX DISEASES AND PROPOSE THERAPIES (Q3158297) (← links)
- “Development of a cell-gene therapy strategy for the treatment of Pompe’s disease” (Q3162240) (← links)
- Role of the human retroelement LINE-1 in the pathogenesis of rare diseases associated with the repair of human DNA. (Q3164294) (← links)
- Biomolecular and bioinformatics resource platform, PRB2 (Q3165724) (← links)
- Biomolecular and bioinformatics resource platform, PRB2 (Q3165773) (← links)
- DEVELOPMENT OF UNIVERSAL T CELLULAS FOR USE IN LEUKEMIA IMMUNOTHERAPY PROTOCOLS (Q3167751) (← links)
- Optimisation of genomic editing for application to gene therapy of monogenic diseases (Q3167757) (← links)
- Cell Therapy Network — Tercel (Q3168575) (← links)
- Cell Therapy Network — Tercel (Q3168680) (← links)
- Biomarkers in urine for non-invasive diagnosis of renal pathology in systemic autoimmune diseases (Q3171967) (← links)
- National Institute of Bioinformatics (Q3173362) (← links)
- Impact of the Listeo+ app on reducing cancellations of surgical interventions, improving patient safety and acceptability by professionals and patients (Q3176446) (← links)
- Combination Therapy with Mesenchymal Cells and Umbilical Cord T-regulatory Cells in Diabetes Mellitus Type1 (Q3176483) (← links)
- Development of an integrated system for personalised medicine oriented to diagnosis and discovery of disease genes using next generation sequencing (Q3177401) (← links)
- Development of human models of childhood acute megakaryoblastic leukemias based on human pluripotent cells for the identification of new therapeutic targets (Q3179299) (← links)
- “Cellular therapy of the pigmentary epithelium of the retina in hereditary retinal dystrophys” (Q3181928) (← links)
- Pax8, Deciphering new targets in the diagnosis and treatment of Gestational Diabetes (Q3184630) (← links)
- Development of Innovative Therapies and Nanotechnology for Clinical Application in Age-Related Macular Degeneration (AMD-Hope). (Q3188126) (← links)
- MULTIFUNCTIONAL NANOMATERIALS AIMED AT GLIAL TUMORS FOR MOLECULAR IMAGING AND COMBINED TREATMENT BY CONTROLLED RELEASE OF PHARMACOS AND THERMOTHERAPY. (Q3193885) (← links)
- Elucidating the contribution of ADAMTS1 protease to neovascularisation and tumor plasticity. Studies of vascular niche and tumor microenvironment. (Q3199519) (← links)
- Preclinical study of treatment of spinal stem cell spinal lesions derived from induced stem cells (Q3200505) (← links)
- ADAMTS1 extracellular protease modulating paper in melanoma: Effects on vasculature and macrophages populations in the tumor microenvironment (Q3200982) (← links)
- Preparation of a cell medicinal product based on obtaining differentiated insulin-producing cells from human pluripotent cells (Q3201479) (← links)
- Evaluation of inhibition of liponogenesis as a therapeutic weapon for protection against metabolic syndrome and the promotion of healthy aging. (Q3203207) (← links)
- Platform for morphological and functional analysis at single cell level? (Q3204135) (← links)
- CABIMER_RESEARCH SUPPORT UNITS (Q3204222) (← links)
- Role of predominant glycoprotein A in repetitions (GARP) in cancer (Q3208631) (← links)
- Characterisation of Four Genes Associated to Islots: From their Physiological Impacts to the Development of Drugs for the Treatment of Diabetes (Q3210589) (← links)
- SEARCH FOR USEFUL BIOLOGICAL MARKERS FOR THE DIAGNOSIS AND FOLLOW-UP OF LUPIC NEPHRITIS (Q3210623) (← links)
- Platform National Biobank Network (Q3211187) (← links)
- LRH-1/NR5A2 AND THE PHYSIOLOGY OF THE PANCREATIC ISLET: FROM ORGANOGENESIS AND SURVIVAL TO IMMUNITY-MEDIATED REGENERATION (Q3212216) (← links)
- MANAGEMENT OF THE TRAINING OF HEALTH SCIENCE SPECIALISTS AT SSPA (Q3266740) (← links)
- Individualised and Personalised Health Care System, oriented to Prevention, Pre-Assistance and Health Self-Management (em-Phasys) (Q4656457) (← links)
- Improvement OF WELCOME AND SAFETY OF PATIENT IN ASSISTENT PROCESSES MEDIAN COLABORATIVE SYSTEMS (m-Listable) (Q4657633) (← links)
- CRYO-PRESERVATION PROCESS OPTIMISATION FOR ADVANCED THERAPIES (Q4687391) (← links)
- DEVELOPMENT OF A THERAPY FOR THE TREATMENT OF GENETIC VARIANTS OF ALPHA-SYNUCLEIN IN PARKINSON’S DISEASE (Q4689023) (← links)